BioKangtai’s adenovirus vector COVID-19 vaccine obtained EUA in Indonesia


SHENZHEN, China, Nov. 3, 2021 /PRNewswire/ — As reported by Indonesian National Agency of Drug and Food Control (BPOM), BPOM grants the Emergency Use Authorization (EUA) for COVID-19 Vaccine (ChAdOx1-S[recombinant])/KconecaVac manufactured by Shenzhen Kangtai Biological Products Co., Ltd. It is understood that this is China’s second adenovirus vector COVID-19 vaccine approved for emergency use overseas.

BPOM source:

Cision View original content:

Source: Shenzhen Kangtai Biological Products Co.,Ltd.